Achieve 5× platelet concentration from just 4.5 mL of blood. Built for both dogs and cats. No proprietary kits. 80% lower cost per procedure. Dual patent protection across EU and USA.
PlatGen is a university spin-off of the Universidade de Trás-os-Montes e Alto Douro (UTAD), created to commercialise a breakthrough platelet concentrate (PC) protocol for veterinary regenerative medicine — explicitly validated for both canines and felines.
Our patented double-centrifugation method produces platelet concentrates with approximately 5× the concentration of whole blood baseline, using only 4.5 mL of blood and standard laboratory consumables — no proprietary kits required. This outperforms every commercial system described in the scientific literature for dogs and cats.
We hold a granted European Patent (EP 4 273 231 A1, valid in 38 EPO contracting states) and a pending US patent application (US 2025/0223557 A1, PCT/IB2023/054555, national phase entry September 2024).
Built on peer-reviewed research and validated haematological data published by UTAD veterinary researchers.
The only protocol designed, validated and patented specifically for dogs and cats — the most underserved species in veterinary regenerative medicine.
Standard laboratory consumables only. No proprietary kits, no locked supply chains, no recurring license fees.
EU patent valid in 38 states. US patent pending. The two largest veterinary markets in the world, covered.
A two-spin centrifugation method that recovers approximately 5× platelet concentration from whole blood baseline — in any clinical or research setting for dogs and cats.
| Validated Haematological Results — Canine & Feline PC | Whole Blood (baseline) | PlatGen PC |
|---|---|---|
| Platelets PLT (×10³/mL) | 297.50 (149.0–340.8) | 1,492.00 (890–1,791) |
| Erythrocytes RBC (×10⁶/mL) | 8.65 (8.12–9.39) | 1.20 (0.66–1.44) |
| Leucocytes WBC (×10³/mL) | 7.88 (5.41–9.05) | 4.01 (2.55–6.58) |
| Concentration Factor | — | ~5× baseline |
Source: Clemente Pires et al. (2022). EP 4 273 231 A1. European Patent Office. Values expressed as median (interquartile range).
"For the first time, a protocol achieves ~5× platelet concentration specifically validated in both dogs and cats — outperforming all commercial systems described in veterinary literature, from only 4.5 mL of blood."
Veterinary regenerative medicine is expanding rapidly. Yet the canine and feline segment — the fastest-growing — has no validated, patented product.
VetStem's PrecisePRP Canine (the only FDA-reviewed PRP product):
PlatGen:
Spin-off of the Universidade de Trás-os-Montes e Alto Douro
Vila Real · Portugal
Whether you are a veterinary clinic, an investor, or an industry partner — we want to hear from you.
Implement the PlatGen protocol for dogs and cats in your practice. Early adopter access available in EU and US.
Request Protocol InfoSeed round open · €750K · Dual-market IP. University spin-off. Peer-reviewed science for canines and felines.
Request Investor DeckOEM licensing, research partnerships, and clinical validation collaborations with leading industry players.
Explore Partnerships